Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting
21 sept. 2022 08h34 HE
|
Helsinn Healthcare S.A.
Helsinn presents novel data on Chlormethine gel at EORTC cutaneous lymphomas tumors group annual meeting Data on chlormethine in both clinical trials and real-world settings will be presentedHelsinn...
New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas
14 févr. 2020 08h00 HE
|
Helsinn Healthcare S.A.
New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas Lugano, Switzerland, February 14, 2020 – Helsinn, the Swiss pharmaceutical group focused on...
Helsinn Group supports Satellite Symposium at EORTC CLTF 2018 Annual Meeting
26 sept. 2018 04h00 HE
|
Helsinn Healthcare S.A.
Helsinn Group supports Satellite Symposium at EORTC CLTF 2018 Annual Meeting Lugano, Switzerland, September 26, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care...